Article
Stromal VCAN expression as a potential prognostic biomarker for disease recurrence in stage II–III colon cancer
9 Jun 2016
Abstract excerpt
To develop prognostic biomarkers that can discriminate stage II-III colorectal cancer patients with high risk of postoperative recurrence, we conducted a genome-wide screening of relapse-related genes utilizing multiple microarray cohorts. Among differentially expressed genes between tumor and nontumor, we identified eight candidate genes associated with relapse in two datasets of stage II-III patients (n = 94...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
